Canopy Rivers' PharmHouse Joint Venture Receives Health Canada License
Canopy Rivers Inc (OTC: CNPOF), the venture capital arm of Canopy Growth Corp (NYSE: CGC), announced Monday its PharmHouse Joint venture had obtained a cultivation license from Health Canada.
PharmHouse, in which Canopy Rivers holds a 49% stake, will immediately start cultivation operations at its facility on 190,000 square feet of licensed nursery infrastructure. The company expects to expand cultivation to the entire 1.3 million square feet by the end of the year.
Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 -- Click here to learn more!
Why This Is Important
The other party involved in the joint venture is Mastronardi Produce Limited, a conglomerate of principals and operators of North American agriculture and produce.
PharmHouse's Leamington, Ontario-based greenhouse facility, which Canopy Rivers helped finance, build and facilitated the license application process for, is one of the largest in the world and uses a high degree of automation and lean manufacturing processes inspired by commercial agriculture best practices.
Canopy Rivers stock closed Friday at $2.30 per share.
Related Links:
Canopy Growth, PharmHouse Enter Into Supply Agreement
Canopy Rivers Reports Q4 Earnings
See more from Benzinga
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
